FA
Forefront Analytics Portfolio holdings
AUM
$89.5M
This Quarter Return
+1.25%
1 Year Return
+11.48%
3 Year Return
+24.94%
5 Year Return
+31.9%
10 Year Return
–
AUM
$175M
AUM Growth
+$175M
(-9.6%)
Cap. Flow
-$20.7M
Cap. Flow
% of AUM
-11.82%
Top 10 Holdings %
Top 10 Hldgs %
62.95%
Holding
80
New
1
Increased
22
Reduced
41
Closed
15
Top Buys
| 1 |
iShares ESG Aware MSCI EAFE ETF
ESGD
|
$5.7M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
$116K |
| 3 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
$93.8K |
| 4 |
Pfizer
PFE
|
$60.9K |
| 5 |
Jasper Therapeutics
JSPR
|
$53.5K |
Top Sells
| 1 |
Nuveen ESG Large-Cap Value ETF
NULV
|
$6.37M |
| 2 |
iShares Gold Trust
IAU
|
$1.75M |
| 3 |
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
|
$1.57M |
| 4 |
First Trust North American Energy Infrastructure Fund
EMLP
|
$1.54M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
$1.49M |
Sector Composition
| 1 | Healthcare | 1.3% |
| 2 | Technology | 0.42% |
| 3 | Financials | 0.29% |
| 4 | Industrials | 0.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SURF
76
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| – | – |
-61,156
| Closed | -$42.7K |
|
|
CDAK
77
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
| – | – |
-110,210
| Closed | -$19.2K |
|
78
ALX Oncology
ALXO
$54.6M
| – | – |
-13,037
| Closed | -$58.9K |
|
79
Invesco DB Commodity Index Tracking Fund
DBC
$1.29B
| – | – |
-13,343
| Closed | -$317K |
|
80
Invesco DB Agriculture Fund
DBA
$813M
| – | – |
-40,111
| Closed | -$819K |
|